Homology Medicines (FIXX) News Today → The Gold Grab of the Century (From Colonial Metals) (Ad) Free FIXX Stock Alerts Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHomology Medicines (NASDAQ:FIXX) Stock Price Up 0.8%americanbankingnews.com - April 30 at 1:40 AMmarketbeat.com - March 26 at 6:03 AMHomology Medicines, Inc.: Homology Medicines Declares Distribution to Common Stockholdersfinanznachrichten.de - March 24 at 4:56 AMFIXX Homology Medicines, Inc.seekingalpha.com - March 23 at 9:14 AMHomology Medicines Declares Distribution to Common Stockholdersfinance.yahoo.com - March 18 at 7:34 PMHOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXXbusinesswire.com - February 27 at 3:29 PMHomology Medicines Inc (FIXX)investing.com - February 2 at 1:48 PMHomology Medicines, Inc.: Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiencyfinanznachrichten.de - January 4 at 8:30 AMHomology Medicines gets non-compliance notice from Nasdaqmsn.com - January 4 at 3:29 AMHomology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiencyfinance.yahoo.com - January 3 at 5:05 PMHomology Medicines Stock (NASDAQ:FIXX) Insider Tradesbenzinga.com - December 27 at 11:25 PMHomology Medicines Stock (NASDAQ:FIXX), Short Interest Reportbenzinga.com - December 27 at 11:25 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MIRO, SRC, PATI, FIXXmarkets.businessinsider.com - November 21 at 7:52 AMHOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXXbusinesswire.com - November 17 at 10:18 PMHOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXXbusinesswire.com - November 17 at 8:02 PMBig Pharma-backed startup to go public by merging with gutted Homologybizjournals.com - November 17 at 12:17 PMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Homology Medicines (FIXX), Align Tech (ALGN) and Calidi Biotherapeutics (CLDI)markets.businessinsider.com - November 16 at 8:42 PMHomology Medicines slumps after merger deal with Q32 Biomsn.com - November 16 at 3:41 PMWhy Is Rare Disease Focused Homology Medicines Stock Trading Lower Today?msn.com - November 16 at 3:41 PMFIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholderstmcnet.com - November 16 at 3:41 PMHomology Medicines Shares Drop 38% After Buyout Offer From Q32 Biomarketwatch.com - November 16 at 10:41 AMHomology Medicines To Merge With Q32 Bio; Homology Medicines Down In Pre-marketmarkets.businessinsider.com - November 16 at 10:41 AMQ32 Bio and Homology Medicines Announce Merger Agreementfinance.yahoo.com - November 16 at 10:41 AMHomology Medicines, Inc.: Homology Medicines Reports Third Quarter 2023 Financial Resultsfinanznachrichten.de - November 15 at 10:51 PMHomology Medicines GAAP EPS of -$0.57 misses by $0.15msn.com - November 14 at 9:50 PMHomology Medicines Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 14 at 4:50 PMCan Homology Medicines (NASDAQ:FIXX) Afford To Invest In Growth?finance.yahoo.com - October 28 at 9:41 AMHomology Medicines, Inc.: Homology Medicines Reports Second Quarter 2023 Financial Results and Recent Highlightsfinanznachrichten.de - August 15 at 5:08 PMHomology Medicines Reports Second Quarter 2023 Financial Results and Recent Highlightsfinance.yahoo.com - August 14 at 6:05 PMHomology Medicines (FIXX) Price Target Decreased by 55.71% to 3.16msn.com - August 3 at 3:03 PMHomology lays off 80, explores sale, citing 'tough financing conditions'bizjournals.com - July 28 at 7:16 PMHomology (NASDAQ:FIXX) Mulls Strategic Options; Shares Jumpmsn.com - July 28 at 11:28 AMThe Latest Analyst Ratings for Homology Medicinesmarkets.businessinsider.com - July 28 at 11:28 AMHomology Medicines Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKUfinance.yahoo.com - July 28 at 11:28 AMHomology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKUfinance.yahoo.com - July 28 at 11:28 AMmarketbeat.com - July 27 at 4:08 PMPhenylketonuria Drugs Market: Trends, Demand, Growth, Business Development, Analysis By 2029marketwatch.com - June 22 at 3:32 PMRobert W. Baird Keeps Their Buy Rating on Homology Medicines (FIXX)markets.businessinsider.com - June 22 at 10:25 AMHomology Medicines Announces First Data from IND-Enabling Studies with GTx-mAb Candidate HMI-104 for PNH, Which Demonstrated Sustained Expression of Functional C5mAb Levels, at the ASGCT Annual Meetingfinance.yahoo.com - May 16 at 8:50 AMHomology Medicines (FIXX) Gets a Hold from RBC Capitalmarkets.businessinsider.com - May 15 at 11:40 PMHC Wainwright & Co. Reiterates Homology Medicines (FIXX) Buy Recommendationmsn.com - May 15 at 6:40 PMRobert W. Baird Sticks to Their Buy Rating for Homology Medicines (FIXX)markets.businessinsider.com - May 15 at 8:31 AMChardan Capital Maintains Homology Medicines (FIXX) Buy Recommendationmsn.com - May 12 at 3:04 PMCredit Suisse Reiterates Homology Medicines (FIXX) Neutral Recommendationmsn.com - May 12 at 3:04 PMCredit Suisse Keeps Their Hold Rating on Homology Medicines (FIXX)markets.businessinsider.com - May 12 at 3:04 PMHomology Medicines, Inc.: Homology Medicines Reports First Quarter 2023 Financial Results and Recent Highlightsfinanznachrichten.de - May 12 at 10:03 AMHomology Medicines Reports First Quarter 2023 Financial Results and Recent Highlightstechnews.tmcnet.com - May 11 at 8:16 PMHomology Medicines GAAP EPS of -$0.50 beats by $0.04, revenue of $0.8M misses by $0.21Mseekingalpha.com - May 11 at 8:16 PMHomology Medicines Announces Upcoming Presentations Highlighting its Genetictmcnet.com - May 3 at 10:04 AMHomology Medicines Announces Upcoming Presentations Highlighting its Genetic Medicines Platform, including New Data from IND-Enabling Studies with GTx-mAb Development Candidate HMI-104 for PNH, at ASGCT Annual Meetingfinance.yahoo.com - May 3 at 10:04 AM Get Homology Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for FIXX and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon’s New Device is About to Shock the World (Ad)Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. FIXX Media Mentions By Week FIXX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FIXX News Sentiment▼0.000.42▲Average Medical News Sentiment FIXX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FIXX Articles This Week▼10▲FIXX Articles Average Week Get Homology Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for FIXX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Gain Therapeutics News Eledon Pharmaceuticals News Reneo Pharmaceuticals News Kronos Bio News Checkpoint Therapeutics News BioLineRx News SCYNEXIS News CalciMedica News Kezar Life Sciences News Equillium News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FIXX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Homology Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
